These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9842448)

  • 21. Immunoblot analysis of IgG subclass antibody response against Coxiella burnetii in Balb/c mice.
    Thiele D; Willems H; Glas M
    Acta Virol; 1992 Jan; 36(1):73-8. PubMed ID: 1350177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenic characteristic of the lipopolysaccharides of Coxiella burnetii isolates.
    To H; Hotta A; Yamaguchi T; Fukushi H; Hirai K
    J Vet Med Sci; 1998 Feb; 60(2):267-70. PubMed ID: 9524957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coxiella burnetii antigens for detection of Q fever antibodies by ELISA in human sera.
    Kovácová E; Gallo J; Schramek S; Kazár J; Brezina R
    Acta Virol; 1987 May; 31(3):254-9. PubMed ID: 2888290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coxiella burnetii Lipopolysaccharide: What Do We Know?
    Abnave P; Muracciole X; Ghigo E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The occurrence of Coxiella burnetii in sheep and ticks of the genus Dermacentor in Baden-Wuerttemberg].
    Sting R; Breitling N; Oehme R; Kimmig P
    Dtsch Tierarztl Wochenschr; 2004 Oct; 111(10):390-4. PubMed ID: 15568636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and evaluation of Coxiella burnetii O-polysaccharide antigen as an immunodiagnostic reagent.
    Hussein A; Kovácová E; Toman R
    Acta Virol; 2001 Jun; 45(3):173-80. PubMed ID: 11774896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactivity between Coxiella burnetii and chlamydiae.
    Lukácová M; Melnicáková J; Kazár J
    Folia Microbiol (Praha); 1999; 44(5):579-84. PubMed ID: 10997139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the Q-fever complement fixation test and two commercial enzyme-linked immunosorbent assays for the detection of serum antibodies against Coxiella burnetti (Q-fever) in ruminants : recommendations for use of serological tests on imported animals in New Zealand.
    Kittelberger R; Mars J; Wibberley G; Sting R; Henning K; Horner GW; Garnett KM; Hannah MJ; Jenner JA; Piggott CJ; O'Keefe JS
    N Z Vet J; 2009 Oct; 57(5):262-8. PubMed ID: 19802039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies.
    Hotta A; Kawamura M; To H; Andoh M; Yamaguchi T; Fukushi H; Hirai K
    Infect Immun; 2002 Aug; 70(8):4747-9. PubMed ID: 12117996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical and antigenic characterization of Coxiella burnetii strains isolated in Europe and Mongolia.
    Kovácová E; Vavreková M; Lukácová M; Daiter AB; Tokarevich NK; Karceva NA; Gorbachev EN; Urvolgyi J; Kocianová E; Rehácek J
    Eur J Epidemiol; 1994 Feb; 10(1):9-15. PubMed ID: 7957797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term persistence of Coxiella burnetii after acute primary Q fever.
    Marmion BP; Storm PA; Ayres JG; Semendric L; Mathews L; Winslow W; Turra M; Harris RJ
    QJM; 2005 Jan; 98(1):7-20. PubMed ID: 15625349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of mild acid hydrolysis on the antigenic properties of phase I Coxiella burnetii.
    Schramek S; Brezina R; Kazár J
    Acta Virol; 1978 Jul; 22(4):302-8. PubMed ID: 29469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of anti-Coxiella burnetii antibodies by immunofluorescent technique and enzyme-linked immunosorbent assay.
    Furuya Y; Katayama T; Hara M; Yoshida Y; Imai M; Arashima Y; Kato K; Ogawa M; Hagiwara T
    Jpn J Infect Dis; 2001 Apr; 54(2):75-6. PubMed ID: 11427746
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative diagnostic potential of three serological tests for abortive Q fever in goat herds.
    Rousset E; Durand B; Berri M; Dufour P; Prigent M; Russo P; Delcroix T; Touratier A; Rodolakis A; Aubert M
    Vet Microbiol; 2007 Oct; 124(3-4):286-97. PubMed ID: 17532581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates.
    Hackstadt T
    Infect Immun; 1986 Apr; 52(1):337-40. PubMed ID: 3957431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells.
    Kersh GJ; Oliver LD; Self JS; Fitzpatrick KA; Massung RF
    Vector Borne Zoonotic Dis; 2011 Nov; 11(11):1433-8. PubMed ID: 21867419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of specificity of interaction between synthetic key saccharide components of lipopolysaccharides and monoclonal antibodies to Coxiella burnetii.
    Kovácová E; Cmarko D; Mucha V; Toman R; Ciampor F; Kosma P; Tyczka J; Sekeyová Z
    Acta Virol; 2005; 49(4):261-70. PubMed ID: 16402683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different antigenic properties of lipopolysaccharides isolated from Coxiella burnetii in phase I and pure phase II.
    Schramek S; Brezina R; Visacká E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):356-60. PubMed ID: 6417946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains.
    Kazár J; Gajdosová E; Kovácová E; Valková D
    Acta Virol; 1995 Dec; 39(5-6):243-9. PubMed ID: 8722292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological properties of the lipopolysaccharide-protein complex of Coxiella burnetii.
    Kazár J; Schramek S; Brezina R
    Acta Virol; 1978 Jul; 22(4):309-15. PubMed ID: 29470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.